Transplant Coverage Provision in Great Benefit Policies

The transplant coverage provision in Great Benefit policies is pivotal to the Black family’s dispute with Great Benefit: the policy covering Donny Ray Black named several excluded transplants but did not specifically exclude bone marrow transplantation. A later policy added that exclusion, giving Rudy Baylor a concrete contrast to use at trial and raising the question of why the earlier claim had been denied.

The Black family’s policy and claim

Dot Black told Rudy Baylor that her family had bought its medical policy from Great Benefit Life Insurance Company five years earlier and had paid the premiums without interruption. Donny Ray had acute leukemia, and doctors had identified his identical twin, Ronny Ray Black, as a suitable bone marrow donor. The family said the transplant would cost about $150,000, a sum it could not pay without insurance. Dot described the treatment as covered by the policy; Great Benefit refused the claim.

The refusal came with changing explanations. Great Benefit variously asserted that Donny Ray was no longer covered because he was an adult, that his leukemia was a preexisting condition, and that bone marrow transplantation was not covered or was too experimental. Dot had read the policy repeatedly and maintained that it contained no adult-dependent exclusion. She also said the family’s doctor had reviewed the policy and believed Great Benefit should pay. The dispute therefore concerned not only whether the treatment was medically appropriate, but whether the insurer could find a textual basis for withholding payment.

What the policy excluded

At trial, Leo F. Drummond presented the Black family’s policy as costing $18 a week and argued that it did not require Great Benefit to pay for bone marrow transplantation. The policy’s actual wording complicated that position. It listed exclusions for major organ transplants, including kidney, liver, heart, lung, and eye transplants, but did not name bone marrow. Rudy emphasized the omission: the policy specified exclusions for other transplantable organs yet left bone marrow off the list.

The policy’s denial history had also presented the transplant issue as a succession of different grounds. Dot read the jury seven denial letters, which invoked outright denial, review by another department, the alleged preexisting condition, Donny Ray’s status as an adult outside the household, and the claim that bone marrow transplantation was either excluded or experimental. The changing explanations made the policy language especially consequential: Great Benefit’s position was not confined to a single clear exclusion stated in the contract.

The later policy and the contrast

Before trial, Max Leuberg obtained a newer Great Benefit medical policy and gave it to Rudy to examine. Unlike the Black family’s policy, the newer document expressly excluded all transplants, including bone marrow transplants. Leuberg urged Rudy to use the change as a point of comparison: if bone marrow transplantation had already been excluded by the Black family’s contract, the later express wording invited the question of why Great Benefit had added it.

Rudy put that contrast to Great Benefit chief executive M. Wilfred Keeley. Keeley identified the newer policy as one issued in September 1992 and confirmed that it listed bone marrow among the exclusions. When Rudy asked what the Black family’s policy excluded, Keeley confirmed that it named several major organs but not bone marrow. He agreed that bone marrow was not specifically excluded from that contract. Keeley could not say when the wording had been changed or whether the change occurred after the Black family filed suit. His uncertainty left Rudy able to argue that the newer clause showed the company knew how to exclude bone marrow expressly, while the earlier policy did not do so.

The provision in the larger case

The wording mattered within a broader claims process that could obscure the reason for a refusal. Cooper Jackson described Great Benefit’s practice of initially denying claims, ordering medical records, and passing files between claims and underwriting. According to his account, the departments exchanged instructions and correspondence while the insured received further denials or notices of review. In the Black family’s case, the transplant provision sat among several asserted grounds, making it possible for the dispute to shift from one explanation to another rather than rest on the contract’s actual language.

At trial, medical testimony also challenged Great Benefit’s description of transplantation as experimental. Dr. Walter Kord testified that the low proportion of leukemia patients receiving transplants reflected the difficulty of finding a donor, not that the procedure lacked medical value; Donny Ray had a donor. In his closing argument, Rudy connected that evidence to the policy’s omission and the newer policy’s express exclusion. The contract language thus helped turn an abstract coverage disagreement into a specific comparison the jury could assess: the old policy did not name bone marrow transplantation as excluded, while Great Benefit’s later form did. The evidence establishes the significance of that contrast to the case, without itself supplying the jury’s ultimate decision.